SWM
IDXX icon

Salvus Wealth Management’s Idexx Laboratories IDXX Stock Holding History

Salvus Wealth Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Sell
627
-91
-13% -$51K 0.18% 108
2026
Q1 		$403K Buy
718
+22
+3% +$14.1K 0.23% 96
2025
Q4 		$471K Buy
696
+37
+6% +$25.2K 0.26% 85
2025
Q3 		$421K Buy
659
+46
+8% +$27.9K 0.24% 90
2025
Q2 		$329K Buy
+613
New +$293K 0.19% 99

Other funds holding IDXX

MBI
Montrusco Bolton Investments Montreal, Quebec, Canada $6.46B AUM 26.7% 1-Year Est. Return
CGI
Comgest Global Investors Paris, France $4.55B AUM 11.62% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
MJRIC
Mogy Joel R Investment Counsel Beverly Hills, California $1.75B AUM 17.81% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Salvus Wealth Management's IDXX Position: Q2 2026 in Review

Salvus Wealth Management reduced its Idexx Laboratories (IDXX) stake by 13% in Q2 2026, selling an estimated $51K and leaving 627 shares worth $330K. The position accounts for 0.18% of the portfolio, ranked #108.

Salvus Wealth Management first reported a position in IDXX in Q2 2025 and has held it in 5 quarters since. The position peaked at $471K in Q4 2025. 330 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Salvus Wealth Management held 627 shares of Idexx Laboratories worth $330K as of Q2 2026.
  • Salvus Wealth Management sold 91 Idexx Laboratories shares in Q2 2026, an estimated $51K.
  • Idexx Laboratories made up 0.18% of Salvus Wealth Management's portfolio in Q2 2026, its #108 holding.
  • Salvus Wealth Management first reported a position in Idexx Laboratories in Q2 2025 and has held it in 5 quarters since.
  • Salvus Wealth Management's Idexx Laboratories position peaked at $471K in Q4 2025.
  • 330 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Salvus Wealth Management's 13F filing for Q2 2026, filed 10 Jul 2026.